Patient Safety Competency-Building Program for Healthcare Professionals in Pediatric Cardiac Critical Care in Ethiopia
Development and Evaluation of a Patient Safety Competency-Building Program for Healthcare Professionals in Pediatric Cardiac Critical Care in Ethiopia
This study aims to develop and evaluate a patient safety competency-building program for healthcare professionals involved in pediatric cardiac critical care in Ethiopia. The program consists of educational modules addressing key areas of patient safety and is delivered in person at a tertiary hospital in Addis Ababa, Ethiopia. Patient safety competence is assessed before and immediately after each training round, and acceptability, appropriateness, and feasibility are assessed immediately after each training round as implementation outcomes.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
The patient safety competency-building program comprises nine educational modules delivered across three training rounds, with selected modules provided during each round. Healthcare professionals involved in pediatric cardiac critical care may participate in one or more training rounds, and participants may therefore differ across rounds. For each training round, patient safety competence is assessed before the training and immediately after its completion as a common educational outcome. Medication safety competence is assessed before and immediately after the first training round as a round-specific educational outcome. Acceptability, appropriateness, and feasibility are assessed immediately after each training round as implementation outcomes.
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Addis Ababa
-
Addis Ababa, Addis Ababa, Ethiopia
- Tikur Anbessa Specialized Hospital
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Healthcare professionals involved in pediatric cardiac critical care at Tikur Anbessa Specialized Hospital, including physicians, nurses, perfusionists, and other relevant healthcare professionals
- Able to understand the purpose and procedures of the study and voluntarily provide informed consent
Exclusion Criteria:
- Healthcare professionals who are on leave or are not directly involved in pediatric cardiac critical care at the time of the study
- Individuals who are unable to adequately understand or participate in the educational program conducted in English, even with Amharic language support
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Patient Safety Competency-Building Program
Participants receive a patient safety competency-building program designed for healthcare professionals involved in pediatric cardiac critical care. The program comprises nine educational modules and is delivered in person across three training rounds, with selected patient safety modules provided during each round. |
The patient safety competency-building program consists of nine educational modules: Patient Safety Principles; Teamwork and Communication; Surgical Safety; Medication Safety; Blood Transfusion Safety; Infection Control; Patient Assessment and Clinical Decision-Making; Safety Equipment Management; and Patient Safety Incident Response and Reporting. Selected modules are delivered during each training round through in-person lectures, group discussions, and practical activities. |
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient Safety Competence
Time Frame: Before and immediately after each training round
|
Patient safety competence is measured using the Health Professional Education in Patient Safety Survey (H-PEPSS), a 16-item self-report instrument covering six domains: working in teams with other health professionals, communicating effectively, managing safety risks, understanding human and environmental factors, recognizing and responding to adverse events, and culture of safety. Scores are calculated as the mean of the 16 items, with possible scores ranging from 1 to 5; higher scores indicate greater perceived patient safety competence. |
Before and immediately after each training round
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Medication Safety Competence
Time Frame: Before and immediately after the first training round
|
Medication safety competence is measured using the Medication Safety Competence Scale (MSCS), a 36-item self-report instrument covering six domains: patient-centered medication management, improvement of safety problems, management of effecting factors, safety risk management, multidisciplinary collaboration, and responsibility in the nursing profession. Scores are calculated as the mean of the 36 items, with possible scores ranging from 1 to 5; higher scores indicate greater medication safety competence. |
Before and immediately after the first training round
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Acceptability of the Intervention
Time Frame: Immediately after each training round
|
Acceptability is measured using the Acceptability of Intervention Measure (AIM). The AIM consists of four items rated on a 5-point Likert scale. Scores are calculated as the mean of the four items, ranging from 1 to 5; higher scores indicate greater acceptability of the intervention. |
Immediately after each training round
|
|
Appropriateness of the Intervention
Time Frame: Immediately after each training round
|
Appropriateness is measured using the Intervention Appropriateness Measure (IAM). The IAM consists of four items rated on a 5-point Likert scale. Scores are calculated as the mean of the four items, ranging from 1 to 5; higher scores indicate greater perceived appropriateness of the intervention. |
Immediately after each training round
|
|
Feasibility of the Intervention
Time Frame: Immediately after each training round
|
Feasibility is measured using the Feasibility of Intervention Measure (FIM). The FIM consists of four items rated on a 5-point Likert scale. Scores are calculated as the mean of the four items, ranging from 1 to 5; higher scores indicate greater perceived feasibility of the intervention. |
Immediately after each training round
|
|
Program Satisfaction
Time Frame: Immediately after each training round
|
Program satisfaction is assessed using a questionnaire developed by the research team. The questionnaire includes 5-point ratings of overall satisfaction, individual educational sessions, and five aspects of the educational experience, as well as a 10-point rating of achievement of the program objectives. Higher scores indicate more favorable evaluations. Open-ended questions are included to obtain additional participant feedback. |
Immediately after each training round
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Woong-Han Kim, MD, PhD, Seoul National University Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
Other Study ID Numbers
- H-2607-045-1764
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.